Biogen Inc.
Proposal 1a.
Election of Director: Alexander J. Denner
Caisse vote:
Against
Applicable policy or principle:
PR_05_01
Proposal 1b.
Election of Director: Caroline D. Dorsa
Caisse vote:
For
Applicable policy or principle:
PR_05_01
Proposal 1c.
Election of Director: Nancy L. Leaming
Caisse vote:
For
Applicable policy or principle:
PR_05_01
Proposal 1d.
Election of Director: Richard C. Mulligan
Caisse vote:
For
Applicable policy or principle:
PR_05_01
Proposal 1e.
Election of Director: Robert W. Pangia
Caisse vote:
For
Applicable policy or principle:
PR_05_01
Proposal 1f.
Election of Director: Stelios Papadopoulos
Caisse vote:
For
Applicable policy or principle:
PR_05_01
Proposal 1g.
Election of Director: Brian S. Posner
Caisse vote:
For
Applicable policy or principle:
PR_05_01
Proposal 1h.
Election of Director: Eric K. Rowinsky
Caisse vote:
For
Applicable policy or principle:
PR_05_01
Proposal 1i.
Election of Director: Lynn Schenk
Caisse vote:
For
Applicable policy or principle:
PR_05_01
Proposal 1j.
Election of Director: Stephen A. Sherwin
Caisse vote:
For
Applicable policy or principle:
PR_05_01
Proposal 1k.
Election of Director: Michel Vounatsos
Caisse vote:
For
Applicable policy or principle:
PR_05_01
Proposal 2.
To ratify the selection of PricewaterhouseCoopers LLP as Biogen Inc.'s independent registered public accounting firm for the fiscal year ending December 31, 2018.
Caisse vote:
For
Applicable policy or principle:
PR_06
Proposal 3.
Say on Pay - To approve an advisory vote on executive compensation.
Caisse vote:
For
Applicable policy or principle:
PR_07_06
Proposal 4.
Shareholder proposal requesting certain proxy access bylaw amendments.
Caisse vote:
For
Applicable policy or principle:
PR_05_04
Proposal 5.
Shareholder proposal requesting a report on the extent to which risks related to public concern over drug pricing strategies are integrated into incentive compensation arrangements.
Caisse vote:
For
Applicable policy or principle:
PR_12